Hamada H - Search Results

1

Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.

Hamada H, Suzuki H, Abe J, Suzuki Y, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Honda T, Onouchi Y, Terai M, Hata A. Hamada H, et al. Cytokine. 2012 Dec;60(3):681-5. doi: 10.1016/j.cyto.2012.08.006. Epub 2012 Sep 1. Cytokine. 2012. PMID: 22944461 Clinical Trial.

2

Mortality from congenital cardiovascular malformations in Japan, 1968 through 1997.

Terai M, Niwa K, Nakazawa M, Tatsuno K, Segami K, Hamada H, Kohno Y, Oki I, Nakamura Y. Terai M, et al. Among authors: hamada h. Circ J. 2002 May;66(5):484-8. doi: 10.1253/circj.66.484. Circ J. 2002. PMID: 12030345 Free article.

3

Influence of early repair of tetralogy of fallot without an outflow patch on late arrhythmias and sudden death: a 27-year follow-up study following a uniform surgical approach.

Hamada H, Terai M, Jibiki T, Nakamura T, Gatzoulis MA, Niwa K. Hamada H, et al. Cardiol Young. 2002 Jul;12(4):345-51. doi: 10.1017/s1047951100012944. Cardiol Young. 2002. PMID: 12206557

4

Prognostic impact of vascular leakage in acute Kawasaki disease.

Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Terai M, et al. Among authors: hamada h. Circulation. 2003 Jul 22;108(3):325-30. doi: 10.1161/01.CIR.0000079166.93475.5F. Epub 2003 Jun 30. Circulation. 2003. PMID: 12835221

5

Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease.

Jibiki T, Terai M, Kurosaki T, Nakajima H, Suzuki K, Inomata H, Terashima I, Honda T, Yasukawa K, Hamada H, Kohno Y. Jibiki T, et al. Among authors: hamada h. Eur J Pediatr. 2004 Apr;163(4-5):229-33. doi: 10.1007/s00431-003-1386-5. Epub 2004 Feb 13. Eur J Pediatr. 2004. PMID: 14963702 Clinical Trial.

6

Marked pleural and pericardial effusion with elevated Vascular Endothelial Growth Factor production: an uncommon complication of Kawasaki disease.

Hamada H, Terai M, Honda T, Kohno Y. Hamada H, et al. Pediatr Int. 2005 Feb;47(1):112-4. doi: 10.1111/j.1442-200x.2005.02015.x. Pediatr Int. 2005. PMID: 15693881 No abstract available.

7

[DiGeorge syndrome].

Hamada H, Terai M. Hamada H, et al. Nihon Rinsho. 2006 Jun 28;Suppl 2:46-8. Nihon Rinsho. 2006. PMID: 16817347 Review. Japanese. No abstract available.

8

Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro.

Hamada H, Ebata R, Higashi K, Tateno S, Niwa K, Honda T, Yasukawa K, Terai M. Hamada H, et al. Int J Cardiol. 2007 Aug 9;120(1):66-71. doi: 10.1016/j.ijcard.2006.08.106. Epub 2006 Nov 28. Int J Cardiol. 2007. PMID: 17126928

9

Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.

Higashi K, Terai M, Hamada H, Honda T, Kanazawa M, Kohno Y. Higashi K, et al. Among authors: hamada h. Circ J. 2007 Jul;71(7):1052-9. doi: 10.1253/circj.71.1052. Circ J. 2007. PMID: 17587710 Free article. Clinical Trial.

10

[Treatment for Kawasaki disease--perspective].

Hamada H, Terai M. Hamada H, et al. Nihon Rinsho. 2008 Feb;66(2):360-4. Nihon Rinsho. 2008. PMID: 18260335 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,940 results

Search Page

Filters